Human Erythrocyte Glycolipids Promote HIV-1 Envelope Glycoprotein-Mediated Fusion of CD4+ Cells

By Puri A.   Hug P.   Munoz-Barroso I.   Blumenthal R.  

Biochemical and Biophysical Research Communications, Vol. 242, Iss. 1, 1998-01 ,pp. : 219-225

Elsevier

Access to resources Recommend Favorite

Heparin and its derivatives bind to HIV‐1 recombinant envelope glycoproteins, rather than to recombinant HIV‐1 receptor, CD4

By Harrop Hilary A.   Rider Christopher C.  

Glycobiology, Vol. 8, Iss. 2, 1998-02 ,pp. : 131-137

Oxford University Press

Access to resources Recommend Favorite

Investigations Using Photo Affinity Labeled Analogues Confirm the Binding between sCD4 and the PND of HIV-1, MN

By Dettin M.   Scarinci C.   Seraglia R.   Bello C.D.  

Biochemical and Biophysical Research Communications, Vol. 241, Iss. 2, 1997-12 ,pp. : 584-588

Elsevier

Access to resources Recommend Favorite

Dys-Regulation of Effector CD4+ T Cell Function by the V3 Domain of the HIV-1 gp120 during Antigen Presentation

By Zafiropoulos A.   Baritaki S.   Vlata Z.   Spandidos D.A.   Krambovitis E.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 4, 2001-06 ,pp. : 875-879

Elsevier

Access to resources Recommend Favorite

HIV-1 Envelope Is a Neutral Antagonist to CXCR4 in T-Cells

By Staudinger R.   Wang X.   Bandrés J.C.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 4, 2001-02 ,pp. : 1003-1007

Elsevier

Access to resources Recommend Favorite